During the past decade, Ballarat Oncology and Haematology Services conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ballarat Oncology and Haematology Services" are "Advanced or Inoperable Gastric Cancer" (1 trials), "Gastric Cancer" (1 trials), "Gastroesophageal Junction Cancer" (1 trials), "Solid Tumor" (1 trials) and "Unresectable or Metastatic Melanoma" (1 trials). Many other conditions were trialed in "Ballarat Oncology and Haematology Services" in a lesser frequency.

Most popular intervention types in "Ballarat Oncology and Haematology Services" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "BBI608" (1 trials), "CX-072" (1 trials), "Ipilimumab" (1 trials) and "Paclitaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ballarat Oncology and Haematology Services" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Ballarat Oncology and Haematology Services". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Ballarat Oncology and Haematology Services, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ballarat Oncology and Haematology Services, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".